Home / Peptides

Also called: Semax + Hopantenic acid combination, Semax + Epitalon, Semax + BPC-157

By The Health Stacks Research TeamUpdated September 14, 2026

Semax is a man-made substance that acts like a small protein in the body. It is based on a natural hormone but is changed to last longer and work better. Scientists study it to see how it affects the brain and nervous system. It is mostly used by researchers looking into memory, focus, and how the brain handles stress. It is not a medicine you can buy at a store, and it is mostly for lab use only.

The main reason researchers look at Semax is for its possible effects on the brain. Studies suggest it might help the brain work faster and stay clear under stress. It seems to work by helping brain cells talk to each other and stay healthy. Some research looks at how it might protect the brain from damage. It is also being studied to see if it helps people recover from strokes or injuries to the nervous system.

There is still a lot we do not know about Semax for sure. Most of the proof comes from animal studies, not large tests with people. Because of this, we cannot be certain it is safe or works the same way in humans. There are also rules about who can make and sell it. In the United States, a group of experts voted to allow special pharmacies to make it, but the government has not made a final decision yet. You should be careful because it is not officially approved for general use.

Approved*Semax is an approved medicine in Russia for ischemic stroke, cognitive and neurological indications; it is not approved by the US FDA or the EMA. On July 24, 2026, PCAC voted 8–5 to recommend adding Semax to the Section 503A Bulks List. The recommendation is advisory only — FDA rulemaking (typically 12–24 months) must conclude before any change in legal status. Semax is not on the 503A Bulks List, remains an unapproved new drug, and may not be lawfully compounded by traditional 503A pharmacies in the interim. Verified confidence80–100 — backed by strong, well-corroborated sources (peer-reviewed research, clinical guidelines). Our highest confidence tier.

Regulatory status

Semax is an approved medicine in Russia for ischemic stroke, cognitive and neurological indications; it is not approved by the US FDA or the EMA. On July 24, 2026, PCAC voted 8–5 to recommend adding Semax to the Section 503A Bulks List. The recommendation is advisory only — FDA rulemaking (typically 12–24 months) must conclude before any change in legal status. Semax is not on the 503A Bulks List, remains an unapproved new drug, and may not be lawfully compounded by traditional 503A pharmacies in the interim.

Status as of July 27, 2026↗ source

Benefits

What Semax Helps With

The main themes across 30 research studies, in plain language.

Neuroprotection & cognitive

Cognitive performance & memory

50/100Rated 50/100Source typeUnclassified sourceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 44 underlying claims

Research suggests potential benefits for enhancing memory, attention, learning speed, and overall cognitive performance.

Research examplesBest source ↗

Stroke & brain injury recovery

50/100Rated 50/100Source typeUnclassified sourceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 28 underlying claims

Studies indicate potential to support neurological recovery and protect brain tissue following stroke, trauma, or ischemia.

Research examplesBest source ↗

Neurotrophic factor upregulation

72/100Rated 72/100Source typeEstablished referenceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 27 underlying claims

Research indicates it may stimulate the production of key proteins like BDNF and NGF that support neuron growth and survival.

Research examplesBest source ↗

Stress resilience & mood support

50/100Rated 50/100Source typeUnclassified sourceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 20 underlying claims

Evidence suggests it may modulate stress pathways and neurotransmitters to reduce anxiety without causing sedation.

Research examplesBest source ↗

Neurotransmitter system modulation

50/100Rated 50/100Source typeUnclassified sourceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 18 underlying claims

Research points to effects on dopamine, serotonin, and GABA systems that may influence brain function and behavior.

Research examplesBest source ↗

Neural defense & antioxidant activity

72/100Rated 72/100Source typeEstablished referenceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 15 underlying claims

Studies suggest it may help protect brain cells from oxidative stress, inflammation, and toxic proteins like amyloid-beta.

Research examplesBest source ↗

Vision & optic nerve health

60/100Rated 60/100Source typeSpecialist communityIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 4 underlying claims

Research suggests potential protective effects for the optic nerve and treatment of pathologies like glaucoma.

Research examplesBest source ↗

Gastrointestinal & gut barrier support

72/100Rated 72/100Source typeEstablished referenceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 4 underlying claims

Evidence suggests potential to protect the stomach lining and support the integrity of the intestinal barrier.

Research examplesBest source ↗

Immune modulation & inflammation

60/100Rated 60/100Source typeSpecialist communityIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 9 underlying claims

Research suggests potential to regulate immune response genes and reduce pro-inflammatory mediators.

Research examplesBest source ↗

Gene expression & longevity markers

60/100Rated 60/100Source typeSpecialist communityIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 4 underlying claims

Studies suggest it may influence gene expression profiles and markers associated with aging, such as telomerase activity.

Research examplesBest source ↗

Cellular energy & mitochondrial function

60/100Rated 60/100Source typeSpecialist communityIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 6 underlying claims

Preliminary research indicates potential roles in supporting mitochondrial health and cellular bioenergetics.

Research examplesBest source ↗

Free: The Peptide Stack Cheat-Sheet

You just read the research on Semax. The cheat-sheet maps the most-used peptide stacks — doses, timing, and what to check before buying — on one page.

No spam. Unsubscribe anytime.

How People Use It

2 reported routines — each line links to the source it came from.

From published sources

Routines as reported in peer-reviewed papers, clinical guidance, or vetted media — each linked to the source it came from.

SubQ

  • 2 to 3 drops per nostril, 2 to 3 times daily (200 to 900 mcg/day) 95/100Rated 95/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source

Self-reported & vendor-suggested

Routines shared by users and sellers in forums and product pages — anecdotal, not tested in clinical trials. We show them for completeness, not as a recommendation.

General

  • 200–500 mcg once daily SC (intranasal: 600–1500 mcg/day) 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
    1. Weeks 1–2200 mcg · 12 units (0.12 mL)
    2. Weeks 3–4300 mcg · 18 units (0.18 mL)
    3. Weeks 5–6400 mcg · 24 units (0.24 mL)
    4. Weeks 7–12500 mcg · 30 units (0.30 mL)

mg vs mcg: one milligram (mg) equals 1,000 micrograms (mcg) — multiply by 1,000 going from mg to mcg, divide by 1,000 going from mcg to mg. Mixing the two up is a thousand-fold dosing error: 1 mg taken instead of 1 mcg is a 1,000× overdose; 1 mcg instead of 1 mg is a 1,000× underdose. Always double-check the unit label and the decimal place.

Get Semax

Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.

Evidence

Research Citations (31)

Every claim above traces back to a source you can check — here are 31 of them.

  • Effect of semax on the temporary dynamics of brain-derived neurotrophic factor and nerve growth factor gene expression in the rat hippocampus and frontal cortex

    2008 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study)

    1997 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Semax and selank inhibit the enkephalin-degrading enzymes from human serum]

    2001 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Neuroprotective and antiamnesic effects of Semax during experimental ischemic infarction of the cerebral cortex.

    2006 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Semax and selank inhibit the enkephalin-degrading enzymes from human serum]

    2001 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • N-terminal degradation of ACTH(4-10) and its synthetic analog semax by the rat blood enzymes.

    1991 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Semax in the treatment of glaucomatous optic neuropathy in patients with normalized ophthalmic tone

    2001 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Therapy of peptic ulcer with semax peptide.

    2002 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus.

    2006 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Effects of Semax on dopaminergic and serotoninergic systems of the brain.

    2004 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents.

    2005 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Effects of chronic Semax administration on exploratory activity and emotional reaction in white rats

    2007 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Heptapeptide semax attenuates the effects of chronic unpredictable stress in rats.

    2013 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Semax attenuates the influence of neonatal maternal deprivation on the behavior of adolescent white rats.

    2012 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source
  • Therapeutic possibility of "Semax" for depression

    95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
    Source

Timeline

History & Milestones

Key moments in Semax’s research and regulatory timeline — sourced and dated.

  1. The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysisPublicationMar 24, 2014
    Related:Semax
    90/100Rated 90/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source

News

Latest on Semax

Dated, sourced reporting that mentions Semax.

ConsumerJul 29, 2026

New York Times sorts peptide-therapy hype from evidence across skincare, muscle-building, and longevity

A November 2025 New York Times explainer takes a skeptical consumer lens to the peptide-therapy craze, separating the few uses with reasonable evidence (topical GHK-Cu and Matrixyl-type peptides in skincare) from the largely unproven injectable and "biohacking" market (BPC-157, TB-500, epitalon, semax, selank). Dermatologists frame cosmetic peptides as "sidekicks, not hero ingredients," while endocrinologists warn that growth-hormone-releasing peptides like sermorelin and tesamorelin carry the same long-term risks as HGH — diabetes, certain cancers, and acromegaly. The piece notes that most longevity claims rest on cell-culture or animal data only, and that "research-grade" products have no quality controls.

70/100Rated 70/100Source typeEstablished referenceIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →Read →
RegulatoryFeaturedJul 29, 2026

FDA PCAC 2026: committee backs six peptides for compounding, rejects Emideltide

On July 23–24, 2026, the FDA's Pharmacy Compounding Advisory Committee recommended adding six of seven reviewed peptides (BPC-157, KPV, TB-500, MOTS-c, Epitalon, Semax) to the Section 503A Bulks List and rejected Emideltide/DSIP. The vote is advisory only — not a final FDA decision and not legal authorization to compound. FDA must still complete formal notice-and-comment rulemaking (typically 12–24 months) before any change in legal status.

72/100Rated 72/100Source typeEstablished referenceIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →Read →

Wondering how Semax pricing compares across suppliers? Our original market data shows the full picture.

See the State of the Peptide Market 2026 →

Free: The Peptide Stack Cheat-Sheet

The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.

No spam. Unsubscribe anytime.